New treatment combination proves safe for head and neck cancer patients
Saturday, May 30, 2009 - 17:49
in Health & Medicine
PITTSBURGH, May 30 ? Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy, according to a study sponsored by the Eastern Cooperative Oncology Group and chaired by Ethan Argiris, M.D., associate professor of medicine, University of Pittsburgh School of Medicine, and co-leader of the Head and Neck Cancer Program of the Univ